What Researchers Did
Researchers reported on the carboxyhemoglobin half-life during hyperbaric oxygen therapy in an 81-year-old male patient with carbon monoxide poisoning and lung dysfunction.
What They Found
The patient's initial carboxyhemoglobin (COHb) level was 34.4%, decreasing to 5.9% before hyperbaric oxygen (HBO₂) and 3.3% after 22 minutes at 3 atmospheres absolute (ATA) HBO₂. The calculated COHb half-life was 95 minutes before HBO₂ and an estimated 53 minutes during HBO₂ at 3 ATA, which is longer than the commonly cited 23 minutes. This longer half-life was attributed to the patient's respiratory failure and lung dysfunction.
What This Means for Canadian Patients
Canadian patients with carbon monoxide poisoning, particularly those with existing lung or heart conditions, may experience a longer carboxyhemoglobin clearance time during hyperbaric oxygen therapy. This implies that treatment protocols might need to consider individual patient factors beyond the commonly cited half-life to ensure effective detoxification.
Canadian Relevance
This study has no direct Canadian connection.
Study Limitations
As a case report, the findings are based on a single patient and may not be generalizable to all carbon monoxide poisoned individuals.